Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−2.95 EUR
−58.60 M EUR
1.82 M EUR
19.91 M
About Insight Molecular Diagnostics Inc.
Sector
Industry
CEO
Joshua Riggs
Website
Headquarters
Nashville
Founded
2009
ISIN
US68235C2061
FIGI
BBG014J9TM64
Insight Molecular Diagnostics, Inc. is a molecular diagnostics company, which engages in the development and commercialization of diagnostic tests for the detection of cancer, including molecular diagnostic services to pharmaceutical customers. Its products include DetermaRx and DetermaIO. The firm also offers pharmaceutical services like multi-analyte test development and clinical trial services. The company was founded in September 2009 and is headquartered in Nashville, TN.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 7OC0 is 2.70 EUR — it has decreased by −1.46% in the past 24 hours. Watch Insight Molecular Diagnostics Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange Insight Molecular Diagnostics Inc. stocks are traded under the ticker 7OC0.
We've gathered analysts' opinions on Insight Molecular Diagnostics Inc. future price: according to them, 7OC0 price has a max estimate of 6.91 EUR and a min estimate of 3.45 EUR. Watch 7OC0 chart and read a more detailed Insight Molecular Diagnostics Inc. stock forecast: see what analysts think of Insight Molecular Diagnostics Inc. and suggest that you do with its stocks.
7OC0 reached its all-time high on Apr 12, 2024 with the price of 4.80 EUR, and its all-time low was 2.28 EUR and was reached on Apr 24, 2024. View more price dynamics on 7OC0 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
7OC0 stock is 3.79% volatile and has beta coefficient of −0.25. Track Insight Molecular Diagnostics Inc. stock price on the chart and check out the list of the most volatile stocks — is Insight Molecular Diagnostics Inc. there?
Today Insight Molecular Diagnostics Inc. has the market capitalization of 60.69 M, it has decreased by −1.26% over the last week.
Yes, you can track Insight Molecular Diagnostics Inc. financials in yearly and quarterly reports right on TradingView.
Insight Molecular Diagnostics Inc. is going to release the next earnings report on Nov 6, 2025. Keep track of upcoming events with our Earnings Calendar.
7OC0 earnings for the last quarter are −0.25 EUR per share, whereas the estimation was −0.20 EUR resulting in a −30.43% surprise. The estimated earnings for the next quarter are −0.18 EUR per share. See more details about Insight Molecular Diagnostics Inc. earnings.
Insight Molecular Diagnostics Inc. revenue for the last quarter amounts to 439.73 K EUR, despite the estimated figure of 248.30 K EUR. In the next quarter, revenue is expected to reach 243.73 K EUR.
7OC0 net income for the last quarter is −8.27 M EUR, while the quarter before that showed −6.17 M EUR of net income which accounts for −34.12% change. Track more Insight Molecular Diagnostics Inc. financial stats to get the full picture.
No, 7OC0 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 6, 2025, the company has 49 employees. See our rating of the largest employees — is Insight Molecular Diagnostics Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Insight Molecular Diagnostics Inc. EBITDA is −19.36 M EUR, and current EBITDA margin is −1.15 K%. See more stats in Insight Molecular Diagnostics Inc. financial statements.
Like other stocks, 7OC0 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Insight Molecular Diagnostics Inc. stock right from TradingView charts — choose your broker and connect to your account.